What I gather from today's announcement is that new Customer announcement is still tricky in US and seems to be in next quarter, however today's announcement has proven 4DX technology's XV LVAS® is ready for commercialisation in such a colossal market. I believe there will be something cheerful information in coming quarterly report to make shareholders gain confidence.
Ann: 4DMedical progresses towards full reimbursement in the US, page-3
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add 4DX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
43.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $176.5M | |||
| Open | High | Low | Value | Volume |
| 42.5¢ | 43.0¢ | 41.5¢ | $46.59K | 111.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 87061 | 42.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 43.0¢ | 9979 | 1 |
View Market Depth
| Last trade - 16.10pm 28/08/2024 (20 minute delay) ? |
| 4DX (ASX) Chart |